Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 2012 Mar;80(3):1302. doi: 10.1128/IAI.06258-11

Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella enterica Serovar Typhimurium msbB Mutant

Qingke Kong 1, David A Six 1, Qing Liu 1, Lillian Gu 1, Kenneth L Roland 1, Christian R H Raetz 1, Roy Curtiss III 1
PMCID: PMC3294674

ERRATUM

Volume 79, no. 12, p. 5027–5038, 2011. Page 5027, Abstract, lines 3 to 5 should read: While SalmonellamsbB mutants lacking the myristate chain in lipid A were investigated widely as an anticancer vaccine, inclusion of the msbB mutation in a Salmonella vaccine to deliver heterologous antigens has not been studied extensively.

Page 5028, column 2, line 7: “(27, 32, 33, 55)” should read “(27, 32, 33, 33a, 55).”

Page 5038, References: The following reference was inadvertently omitted.

References

  • 33a. McKelvie ND, et al. 2008. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen. FEMS Immunol. Med. Microbiol. 52:237–246 [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES